Rive Sarfstein Selected Research

Laron Syndrome (Syndrome, Laron)

12/2021	The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
11/2021	MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
11/2020	Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
7/2019	Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
1/2019	Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
1/2018	Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
1/2018	Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rive Sarfstein Research Topics

Disease

18	Neoplasms (Cancer) 12/2021 - 08/2005
10	Breast Neoplasms (Breast Cancer) 12/2022 - 08/2005
9	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 01/2011
7	Laron Syndrome (Syndrome, Laron) 12/2021 - 01/2018
3	Dwarfism 12/2021 - 07/2019
3	Carcinoma (Carcinomatosis) 01/2013 - 06/2012
2	Insulin-Like Growth Factor I Deficiency 12/2021 - 01/2019
2	Wilms Tumor (Wilm's Tumor) 11/2006 - 08/2005
1	Uterine Neoplasms (Uterine Cancer) 12/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Obesity 11/2020
1	Growth Disorders 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Brain Concussion (Cerebral Concussion) 05/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2010

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 12/2021 - 05/2010
10	Insulin-Like PeptidesIBA 01/2021 - 11/2006
10	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2013 - 08/2005
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2005
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 11/2006
5	Transcription Factors (Transcription Factor)IBA 01/2016 - 08/2005
4	Growth Hormone (Somatotropin)IBA 11/2021 - 01/2016
4	Biological ProductsIBA 01/2020 - 12/2006
3	Messenger RNA (mRNA)IBA 12/2022 - 06/2006
3	Somatotropin Receptors (Growth Hormone Receptor)IBA 12/2021 - 07/2019
3	Insulin ReceptorIBA 06/2020 - 01/2012
3	Estrogen ReceptorsIBA 01/2012 - 12/2006
2	Hormones (Hormone)IBA 12/2022 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 01/2018 - 05/2015
2	Estrogen Receptor alphaIBA 12/2006 - 08/2005
1	Odorant Receptors (Odorant Receptor)IBA 12/2021
1	ORALIT (ORS)IBA 12/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Small Interfering RNA (siRNA)IBA 11/2019
1	FilaminsIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	LigandsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	methyl jasmonateIBA 10/2014
1	dalotuzumabIBA 07/2013
1	BiguanidesIBA 01/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Cyclin D1IBA 01/2011
1	Histones (Histone)IBA 01/2011
1	Vorinostat FDA Link 01/2011
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2010
1	StreptavidinIBA 03/2010
1	Carrier Proteins (Binding Protein)IBA 03/2010
1	DNA (Deoxyribonucleic Acid)IBA 03/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006
1	LuciferasesIBA 12/2006
1	Sp1 Transcription FactorIBA 12/2006
1	Caveolin 1IBA 11/2006
1	WT1 ProteinsIBA 08/2005

Therapy/Procedure

4	Therapeutics 12/2019 - 07/2012
1	Drug Therapy (Chemotherapy) 07/2013